Skip to main content
OpenTrials

Clinical trial condition

Respiratory Hypersensitivity

Explore clinical trials studying Respiratory Hypersensitivity. Study availability and eligibility vary by location and protocol.

4,459 public trials 325 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Hypersensitivity trial results

Completed

6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old

NCT01462344

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Mobile, Alabama, United States
  • GSK Investigational Site Montgomery, Alabama, United States
View all 530 locations
View Trial Details
Completed

SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma.

NCT01475721

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Athens, Alabama, United States
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Birmingham, Alabama, United States
View all 808 locations
View Trial Details
Completed

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma Control

NCT02281318

Conditions
Asthma, Bronchial Diseases, Eosinophilia, +12 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Fresno, California, United States
  • GSK Investigational Site Long Beach, California, United States
View all 144 locations
View Trial Details
Completed

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

NCT01691521

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Newport Beach, California, United States
  • GSK Investigational Site Riverside, California, United States
  • GSK Investigational Site Rolling Hills Estates, California, United States
View all 134 locations
View Trial Details
Completed

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol 100/25 Microgram (mcg) Inhalation Powder, Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Fluticasone Propionate 250 mcg Inhalation Powder in Adults and Adolescents With Persistent Asthma

NCT02301975

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Huntington Beach, California, United States
  • GSK Investigational Site Riverside, California, United States
  • GSK Investigational Site Rolling Hills Estates, California, United States
  • GSK Investigational Site San Diego, California, United States
View all 179 locations
View Trial Details
Completed

A Study to Investigate the Efficacy, Safety, and Tolerability of Repeat Doses of Inhaled GSK2269557 in Adults With Persistent, Uncontrolled Asthma

NCT02567708

Conditions
Asthma, Bronchial Diseases, Chronic Disease, +11 more
Locations
  • GSK Investigational Site Munich, Bavaria, Germany
  • GSK Investigational Site Rüdersdorf, Brandenburg, Germany
  • GSK Investigational Site Frankfurt am Main, Hesse, Germany
  • GSK Investigational Site Frankfurt am Main, Hesse, Germany
View Trial Details
Completed

Evaluation of Efficacy and Safety of E004 in Children With Asthma

NCT01460511

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Amphastar Site 5 Costa Mesa, California, United States
  • Amphastar Site 8 Orange, California, United States
  • Amphastar Site 4 Stockton, California, United States
  • Amphastar Site 2 Medford, Oregon, United States
View Trial Details

Related conditions